Navigation Links
Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
Date:9/2/2008

ations in the field of atrial fibrillation in the last twenty years.

Multaq(R) has been granted a priority review by the U.S. Food and Drug Administration (FDA) and a registration dossier is also under regulatory review by the European Medicines Agency (EMEA).

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, contributes to improving life by providing a broad offering of medicines, vaccines, and integrated healthcare solutions adapted to local needs and means.

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include product development, product potential projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMEA, regarding whether and w
'/>"/>

SOURCE Sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
2. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
3. Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies
4. Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema
5. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
6. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
7. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
8. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
9. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
10. Arpida Provides Further Comments on the Pivotal Phase III Trials
11. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 /CNW/ - The Taskforce representing Canada,s ... the hard work that the Minister and Health Canada have ... program recognizes the needs of the thalidomide survivors, and more ... year, tax free, with annual adjustments for inflation. ... payments of $100,000 based on the severity of their disability, ...
(Date:5/22/2015)... More than fifty years ago, Thalidomide was approved by Health ... Tragically, Thalidomide caused serious and permanent physical and emotional damage ... been provided to survivors over the years from sources including ... in 1991 and settlements from drug companies. ... support, we have a clear moral obligation to help meet ...
(Date:5/22/2015)... 2015 The Assistance Fund announces the addition ... financial assistance for copay to individuals diagnosed with Melanoma. ... addition of the Melanoma Copay Assistance Program to our ... executive director. "With each additional program we are closer ... where no one is denied access to medications due ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3The Assistance Fund Adds Melanoma Assistance Program 2
... 5, 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ... the Company intends to release its first quarter 2011 financial ... of the U.S. financial markets.  The Company will also host ... on April 27, 2011 to discuss its financial results and ...
... more than $226 million to Arizona,s economy in 2010, ... by a university professor. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO ... to state economic development officials and legislators, showed that ... in the state. The analysis was conducted ...
Cached Medicine Technology:Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings 2Express Scripts Injects $226 Million Into Arizona Economy, Study Finds 2
(Date:5/22/2015)... May 22, 2015 Carnegie Science ... today announced a new partnership to develop BodyTech, a ... region. The initiative includes a new exhibit at the ... demonstration theater, and a new traveling science show, Anatomy ... of 2015. , Designed to explore a wide ...
(Date:5/22/2015)... May 22, 2015 Power Systems is proud ... the 2015 race season. Drobeck is in his second year ... a firefighter with the Missoula Fire Department in Missoula, MT. ... Pro in 2014. During his career, he has had 15 ... Drobeck recorded top 10 finishes in all seven of his ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 The ... Plaza Dental announces that they are now offering ... and other dental treatments. At consultations, patients can ... Questions regarding what certain treatments can achieve and ... covered during this initial appointment. If treatments are ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 A ... at the American Society of Clinical Oncology (ASCO)’s ... improved survival rates for those patients who received ... regimen of pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is ... and it is already routinely used to treat ...
(Date:5/22/2015)... AZ (PRWEB) May 22, 2015 In ... Olympics, Parker and Sons is offering to donate $5 ... installing an AC unit or water softening system. Customers ... behalf; Parker and Sons gets business; and the Special ... , The Special Olympics helps over 4.4 million athletes, ...
Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... Calif., April 18 Accenx Technologies, Inc., a,leading ... care data integration solutions, announces today R. Scott ... & Marketing., Mr. Harper is a results-driven ... in establishing strong sales organizations,working in unison with ...
... Charity Event to Benefit Sharp Rehabilitation Services -, ... Diego Business Clubs,America will hold its second annual ... Barnes Tennis Center in Point Loma on June ... recreational athletes from throughout California are,expected to participate. ...
... the 21st Congress of the European College of Neuropsychopharmacology ... Congress is the largest annual meeting on psychopharmacology and ... attended by more than 6,000 participants (clinical and basic ... from all over the world. , This years ...
... INDIANAPOLIS, April 18 WellPoint, Inc. (NYSE:,WLP) today announced ... its,State Sponsored Business division, effective April 21, 2008., ... leading WellPoint,s,Medicaid business division which currently serves more than ... fortunate to add the quality of experience and,expertise that ...
... illness doesn,t ease the problem, experts say , , FRIDAY, April ... is only connected to other conditions is hampering the development ... , It,s one of two studies on chronic cough published ... papers are by the same authors: Kian Fan Chung of ...
... in Centers for Comprehensive Women,s Care program, ... has designated Baptist Memorial Hospital for Women as ... Care (CCWC) program., The CCWC program recognizes ... health care with a focus on quality and,patient-centered ...
Cached Medicine News:Health News:Accenx Technologies Announces New Leadership in Sales and Marketing Division 2Health News:21st Congress of the College of Neuropsychopharmacology 2Health News:WellPoint Appoints Kevin R. Hayden as President of State Sponsored Business 2Health News:Health Woes Not Always to Blame for Chronic Cough 2Health News:BlueCross Recognizes Baptist Women's Hospital 2
... sized High-Throughput Submarine Systems are designed ... from microtitre plates. Analyze high numbers ... oligos or PCR products simultaneously. The ... accuracy and speed with additional savings ...
... Dodeca cell runs up to 12 mini ... minutes. Handcast gels can be poured 12 ... 485 gradient former and Mini-PROTEAN 3 multi-casting ... reproducibility. Alternatively, Ready Gel precast gels offer ...
... Criterion Dodeca cell, a component of the Criterion ... to 12 Criterion gels in a single run. ... 8.7 cm) than the traditional mini gel. They ... give you the optimal combination of separation and ...
... runs up to 12 mini gels under ... gels can be poured 12 at a ... former and Mini-PROTEAN 3 multi-casting chamber, eliminating ... Ready Gel precast gels offer the convenience ...
Medicine Products: